Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions

Journal of Cellular Physiology

Volumn 177, Issue 2, 1998, Pages 364-376

  Liu, Yuan ^a,b   Riley, Lee B ^a,c   Bohn, Shirley A ^a   Boice, Judith A ^a,b   Stadler, Patrizia B ^a   Sherley, James L ^a,d  

^a FOX CHASE CANCER CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ST LUKE S HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE; OXIDOREDUCTASE; PROTEIN P53;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GROWTH INHIBITION; HYPOTHESIS; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION; IMP DEHYDROGENASE; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 0031691904     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9     Document Type: Article

References (61)

1. Allison, A.C., Kowalski, W.J., Muller, C.D., and Eugui, E.M. (1993) Mechanisms of action of mycophenolic acid. Ann. N.Y. Acad. Sci., 696:63-87.
2. Attardi, L.D., Lowe, S.W., Brugarolas, J., and Jacks, T. (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J., 15:3693-3701.
3. Baker, S.J., Fearon, E.R., Nigro, J.M., Hamilton, S.R., Preisinger, A.C., Jessup, J.M., van Tuinen, P., Ledbetter, D.H., Barker, D.F., Nakamura, Y., White, R., and Vogelstein, B. (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science, 244:217-221.
4. Barak, Y., Juven, T., Haffner, R., and Oren, M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J., 12:461-468.
5. Bargonetti, J., Manfredi, J.J., Chen, X., Marshak, D.R., and Prives, C. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wildtype but not from oncogenic mutant p53 protein. Genes Dev., 7:2565-2574.
6. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T., and Hannon, G.J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 377:552-557.
7. Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev., 10:2438-2451.
8. Cho, Y., Gorina, S., Jeffrey, P.D., and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex; understanding tumorigenic mutations. Science, 265:346-355.
9. Cohen, M.B., Maybaum, J., and Sadee, W. (1981) Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells. J. Biol. Chem., 256:8713-8717.
10. Collart, F.R. and Huberman, E. (1988) Cloning and sequence analysis of the human and Chinese hamster inosine-5′-monophosphate dehydrogenase cDNAs. J. Biol. Chem., 263:15769-15772.
11. De Oca Luna, R.M., Wagner, D.S., and Lozano, G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 378:203-206.
12. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82:675-684.
13. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356:215-221.
14. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75:817-825.
15. Evans, C.B. (1997) Investigation of apoptosis in Zn-dependent p53-inducible murine fibroblasts. Masters Thesis, Department of Microbiology, Thomas Jefferson University, Philadelphia, PA.
16. Fakharzadeh, S.S., Trusko, S.P., and George, D.L. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse cell line. EMBO J., 10:1565-1569.
17. Fields, S., and Jang, S.K. (1990) Presence of a potent transcription activating sequence in the p53 protein. Science, 249:1046-1049.
18. Glesne, D.A., and Huberman, E. (1994) Cloning and sequence of the human type II IMP dehydrogenase gene. Biochem. Biophys. Res. Commun., 205:537-544.
19. Glesne, D.A., Collart, F.R., and Huberman, E. (1991) Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides. Mol. Cell. Biol., 11:5417-5425.
20. Harvey, D.M., and Levine, A.J. (1991) p53 alteration is a common event in the spontaneous immortalization of primary balb/c murine embryo fibroblasts. Genes Dev., 5:2375-2385.
21. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M.E., Wiseman, R.W., Pantazis, P., Giovanella, B.C., Tainsky, M.A., Bradley, A., and Donehower, L.A. (1993) In vitro growth characterization of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8:2457-2467.
22. Hochhauser, S.J., Stein, J.L., and Stein, G.S. (1981) Gene expression and cell cycle regulation. Int. Rev. Cytol., 71:95-243.
23. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253:49-53.
24. Jones, S.N., Roe, A.E., Donehower, L.A., and Bradley, A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature, 378:206-208.
25. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51:6304-6311.
26. Kern, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science, 252:1708-1711.
27. Kharbanda, S.M., Sherman, M.L., and Kufe, D.W. (1990) Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL-60 cells. Blood, 75:583-588.
28. Kinzler, K.W., and Vogelstein, B. (1996) Life (and death) in a malignant tumour. Nature, 379:19-20.
29. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358:15-16.
30. Liu, Y., Bohn, S.A., and Sherley, J.L. (1998) Inosine-5′-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. Mol. Biol. Cell, 9:15-28.
31. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Jr., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., and Friend, S.H. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250:1233-1238.
32. McNeall, J., Sanchez, A., Gray, P.P., Chesterman, C.N., and Sleigh, M.J. (1989) Hyperinducibie gene expression from a metallothionein promoter containing additional metal-responsive elements. Gene, 76:81-88.
33. Meyuhas, O., and Perry, R.P. (1980) Construction and identification of cDNA clones for mouse ribosomal proteins: Application for the study of r-protein gene expression. Gene, 10:113-129.
34. Meyuhas, O., Thompson, E.A., and Perry, R.P. (1987) Glucocorticoids selectively inhibit translation of ribosomal protein mRNAs in P1789 lymphosarcoma cells. Mol. Cell. Biol., 7:2691-2699.
35. Michieli, P., Chedid, M., Lin, D., Pierce, J.H., Mercer, W.E., and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54:3391-3395.
36. Miyashita, T., and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80:293-299.
37. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Lieberman, D.A., Hoffman, B., and Reed, J.C. (1994) Tumor suppresser p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9:1799-1805.
38. Morgenstern, J.P., and Land, H. (1990) Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res., 18:1068.
39. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74:609-619.
40. Pavletich, N.P., Chambers, K.A., and Pabo, C.O. (1993) The DNA-binding domain of p53 contains the four conserved regions and major mutation hot spots. Genes Dev., 7:2556-2564.
41. Pietenpol, J.A., and Vogelstein, B. (1993) No room at the p53 inn. Nature, 365:17-18.
42. Raycroft, L., Wu, H., and Lozano, G. (1990) Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science, 249:1049-1051.
43. Rizzo, M.T., Tricot, G., Hoffman, R., Jayaram, H.N., Weber, G., Garcia, J.G.N., and English, D. (1990) Inosine monophosphate genase inhibitors. Probes for investigations of the functions nine nucleotide binding proteins in intact cells. Cell. Signaling, 2:509-519.
44. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Analysis of RNA. In: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2nd ed., pp. 7.43-7.52.
45. Selvakumaran, M., Lin, H.-K., Miyashita, T., Wang, H.G., Krajewski, S., Reed, J.C., Hoffman, B., and Lieberman, D. (1994) Immediate early up-regulation of bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways. Oncogene, 9:1791-1798.
46. Senda, M., and Natsumeda, Y. (1994) Tissue-differential exression of two distinct genes for human IMP dehydrogenase (E. C. 1.1.1.205). Life Sci., 54:1917-1926.
47. Sherley, J.L. (1991) Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J. Biol. Chem., 266:24815-24828.
48. Sherley, J.L. (1996) The p53 tumor suppressor gene as regulator of somatic stem cell renewal division. Cope, 12:9-10.
49. Sherley, J.L., and Kelly, T.J. (1988) Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem., 263:8350-8358.
50. Sherley, J.L., Stadler, P.B., and Johnson, D.R. (1995a) The p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics. Proc. Natl. Acad. Sci. USA, 92:136-140.
51. Sherley, J.L., Stadler, P.B., and Stadler, J.S. (1995b) A quantitative method for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells. Cell Prolif., 28:137-144.
52. 1 cyclin-dependent kinases. Genes Dev., 9:1149-1163.
53. Srivastava, S., Zou, Z., Pirollo, K., Blattner, W. and Chang, E.H. (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348:747-749.
54. Stadler, P.B., Pennacchi, J., and Sherley, J.L. (1994) Inosine-5′-monophosphate dehydrogenase activity is maintained in immortalized murine cells growth-arrested by serum deprivation. Adv. Enzyme Regul., 34:91-106.
55. Sugano, T., Nitta, M., Ohmori, H., and Yamaizumi, M. (1995) Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle. Jpn. J. Cancer Res., 86:415-418.
56. Szekeres, T., Fritzer, M., Pillwein, K., Felzmann, T., and chiba, P. (1992) Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin. Life Sci., 51:1309-1315.
57. Tiedeman, A.A., and Smith, J.M. (1991) Isolation and sequence of a cDNA encoding mouse IMP dehydrogenase. Gene, 97:289-293.
58. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., Abe, S., Matsuo, I., Y., and Aizawa, S. (1993) Enhanced proliferation potential in culture of cells from p53-deficient mice. Oncogene, 8:3313-3322.
59. Vogelstein, B., and Kinzler, K.W. (1992) p53 function and dysfunction. Cell, 70:523-526.
60. Wu, X. Bayle, J.H., Olson, D., and Levine, A.J. (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7:1126-1132.
61. Zimmermann, A.G., Spychala, J., and Mitchell, B.S. (1995) Characterization of the human inosine-5′-monophosphate type II gene. J. Biol. Chem., 270:6808-6814.